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1. Introduction 
Mitochondria are responsible for the supply of the majority of ATP in human cells  
via respiration and oxidative phosphorylation (OXPHOS). Mitochondria also play a central 
role in numerous cellular processes including energy production, intracellular Ca2+ 
homeostasis, biosynthesis of pyridine nucleotides and amino acids, and ǃ-oxidation of fatty 
acids. On the contrary, mitochondria are also involved in the generation of reactive  
oxygen species (ROS), and initiation and execution of apoptotic cell death. Accumulating 
evidence show that defects in one or more of these functions may contribute to 
mitochondrial encephalomyopathies and other neuromuscular diseases. The term 
“mitochondrial encephalomyopathies” was coined by pediatric neurologists to call the 
attention of clinicians when the brain disease was first reported in children with 
mitochondrial alterations in their muscle biopsies (Shapira et al., 1977). Clinically, 
mitochondrial encephalomyopathies are common disorders that are a result of mutations 
affecting genes encoding proteins of important mitochondrial function (Leonard & Schapira, 
2000a). Most mitochondrial diseases, such as mitochondrial myopathy, lactic acidosis and 
stroke-like episodes (MELAS), are maternally inherited and frequently manifested as 
encephalomyopathies (Taylor et al., 2004). Furthermore, typical clinical features of 
mitochondrial encephalomyopathies include weakness and retardation of the heart, skeletal 
muscle and brain, where mitochondria are relatively abundant. Common symptoms of 
mitochondrial encephalomyopathies include loss of cognitive function, sensorineural 
deafness, optic atrophy, fluctuating encephalopathy, ataxia, seizures, dementia, migraine, 
stroke-like episodes, spasticity, cardiomyopathy, proximal myopathy and exercise 
intolerance (Stollberger & Finsterer, 2006). 
Epilepsy and seizures are common features of mitochondrial dysfunction associated with 
mitochondrial encephalomyopathies and have been considered the most common 
neurological disorders. According to the electroencephalograph (EEG) and seizure 
procedures, epilepsy is often an important sign in the early progression of mitochondrial 
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encephalomyopathies (Canafoglia et al., 2001). Epilepsy is characterized by spontaneous and 
recurrent unprovoked seizures that may lead to numerous changes with events of cascades 
at the cellular level of neurons. Neuronal excitability can be affected by mitochondrial 
dysfunction including depletion of ATP, generation of ROS, disruption of Ca2+ homeostasis, 
defects in biosynthesis and metabolism of neurotransmitters. However, the mechanism by 
which mitochondrial dysfunction leads to the onset and progression of epilepsy is still 
unclear. In this article, we focus on the potential role of mitochondrial function in the 
pathophysiology of mitochondrial encephalomyopathies. Firstly, we discuss the biochemical 
consequences of mitochondrial dysfunction-elicited oxidative stress in affected cells of 
patients with mitochondrial encephalomyopathies. Secondly, we address the possible 
molecular mechanisms involving in the regulation of communication between defective 
mitochondria and the nucleus, which is termed “mitochondrial retrograde signaling” in the 
pathogenesis of mitochondrial encephalomyopathies. Moreover, we also explore the role of 
mitochondria in the regulation of Ca2+ homoeostasis in neuron excitability that influences 
the normal function of neurons and proceeds towards epileptic seizures. Finally, we discuss 
the role of stress responsive gene, Sirt1, in the signaling pathway of the cross-talk between 
mitochondria and the nucleus to be a defense mechanism against neuronal degeneration in 
the patients with mitochondrial encephalomyopathies. We believe that the above-mentioned 
information will help us gain a deeper insight into the mechanisms underlying the 
pathogenesis of epilepsy in patients with mitochondrial disease and guide us to develop 
novel therapeutic strategies for better treatment of human diseases caused by mitochondrial 
dysfunction. 
2. Oxidative stress and mitochondrial encephalomyopathies 
Typical mitochondrial myopathy and encephalomyopathies are caused by mutations in the 
mtDNA or nuclear DNA that affect the respiratory chain directly (Bertini & D'Amico, 2009). 
Since mitochondria are responsible for the supply of the majority of ATP in human cells via 
respiration and OXPHOS, the defective mitochondria in affected tissue cells cause not only 
inefficient ATP production but also increased production of ROS. The symptoms of 
mitochondrial encephalomyopathies and neuromuscular disorders caused by mitochondrial 
dysfunction-elicited oxidative stress have been proven to be similar to those documented in 
the patients with mitochondrial diseases (Fernández-Checa et al., 2010). Oxidative stress 
elicited by mitochondrial dysfunction can further increase oxidative damage to various 
biomolecules in mitochondria. Hence, it has been proposed that the vicious cycle is 
propagating in mitochondrial diseases and results in the widely observed accumulation of 
oxidative damage and mutation of mtDNA, which ultimately leads to a progressive decline 
in the bioenergetic function of mitochondria that affects tissue cells in patients with 
mitochondrial encephalomyopathies (Fukui & Moraes, 2008). Recently, Katayama and 
coworkers demonstrated that the occurrence of 8-OHdG-positive neurons was significantly 
increased in the peri-lesional cortices as compared with the non-lesional and control cortices 
in the patients with MELAS syndrome (Katayama et al., 2009). Importantly, the spread 
frequency of stroke-like lesions in MELAS patients was significantly reduced after treatment 
with the antioxidant edaravone. In addition, a key finding was that failure of adaptive 
responses to oxidative stress (e.g., DNA repair system) in the brain during epileptogenesis 
could lead to an increase in the susceptibility of mitochondria to oxidative damage (Jarrett et 
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al., 2008). The mitochondrial base excision repair (BER) pathway involves a highly 
coordinated process catalyzed by the sequential actions of the DNA repair enzymes 8-
oxoguanine glycosylase (OGG1) and DNA polymerase gamma (POLG). It was reported that 
the RNA and protein expression levels of OGG1 and POLG were decreased during chronic 
epilepsy in an animal model (Lin et al., 2010). They found that spontaneous seizures 
coincided with an accumulation of mtDNA damage, increased mitochondrial H2O2, and 
impaired mtDNA repair, which suggest a contribution of mitochondrial defects to 
epileptogenesis. On the other hand, the regulation of antioxidant enzymes against oxidative 
stress in the cells with defective mitochondria also plays an important role in the 
pathophysiology of mitochondrial encephalomyopathies (Wu et al., 2010). Several animal 
models with the disruption of the antioxidant enzymes such as manganese superoxide 
dismutase (Mn-SOD) and glutathione peroxidase 1 (GPx-1) genes could lead to 
neuromuscular disorders that are similar to those documented in the patients with 
mitochondrial diseases (Li et al., 1995; Esposito et al., 2000). Taken together, the increase of 
oxidative stress and oxidative damage and the dysregulation of antioxidant enzymes are 
involved in the deterioration of bioenergetic function of the affected tissues, especially in the 
brain and skeletal muscle from patients with mitochondrial encephalomyopathies, which 
depend on mitochondrial function for supply of most of the ATP (Wei & Lee, 2003). Recent 
studies conducted in our own and other laboratories have provided compelling evidence to 
support the notion that oxidative stress elicited by impairment of the respiratory chain in 
the affected tissues of patients plays a role in the pathogenesis and progression of 
mitochondrial diseases and seizure generation (Waldbaum et al., 2010a; Wu et al., 2010). 
3. Biochemical hallmarks in mitochondrial encephalomyopathies 
A wide spectrum of the clinical phenotypes in the patients with mitochondrial 
encephalomyopathies is mostly associated with the defects in the structure or function of 
mitochondria. The histological and histochemical examinations of affected tissues have 
provided useful clues to determine the mitochondrial defects in the diagnosis of these diseases 
(Alhatou et al., 2004). There are well-established dye-staining methods for the assay of enzyme 
activities of cytochrome c oxidase (COX, Complex IV) and succinate dehydrogenase (SDH, 
Complex II) in affected muscle fibers and brain (DiMauro et al., 2002). Usually, the succinate 
dehydrogenase (SDH) activity staining clearly shows the subsarcolemmal accumulation of 
mitochondria (SDH-positive) and the activity assay of COX is particularly useful in the 
evaluation of mitochondrial myopathies (COX-negative fibers) because Complex IV contains 
subunits encoded by both the mtDNA and nuclear DNA (Taylor et al., 2004). Recently, 
Folbergrová et al. (2010) reported that the persistent inhibition of Complex I led to the 
overproduction of ROS, which could contribute to the neuronal injury in a rat model of 
seizures and in the patients with epileptogenesis. In a previous study, we observed a 
significant decrease in the copy number of mtDNA in the leukocytes of patients with 
mitochondrial encephalomyopathies including MERRF and MELAS syndromes, respectively 
(Liu et al., 2006). The amplitude of change was related to the proportion of mutant mtDNA, 
which may serve as a biomarker in the pathogenesis and progression of the mitochondrial 
diseases. Similarly, a recent study revealed that large amounts of mtDNA with a deletion were 
observed in hippocampal tissues of patients with epilepsy (Guo et al., 2010). Most importantly, 
by the establishment of cybrid cells with mitochondrial dysfunction and primary culture of 
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skin fibroblasts from affected tissues, we have been able to intensively study the pathogenesis 
of mitochondrial encephalomyopathies. Firstly, we found that the glucose metabolism was 
shifted to enhanced anaerobic glycolysis in the cells from patients with mitochondrial 
myopathy and encephalopathy. This is consistent with a previous report that glycolysis is up-
regulated to compensate for the inefficient ATP production by mitochondrial OXPHOS 
(Pallotti et al., 2004). Although the increase in glycolysis occurred in affected cells is still 
equivocal, it revealed cellular adaptation for affected cells to cope with the energy crisis (Qian 
& van Houten, 2010). Secondly, neuronal mitochondria are important for intracellular Ca2+ 
sequestration, which suggests that mitochondria can modulate neuronal excitability and 
synaptic transmission which are altered in the patients with epilepsy (Tang & Zucker, 1997). 
Indeed, loss of Ca2+ buffering in hippocampal mitochondria has been demonstrated in kainate-
treated chronic epileptic rats (Kunz et al. 1999). Besides, substantial alterations of 
mitochondrial Ca2+ homeostasis were also the predominant feature in cybrids harboring the 
mtDNA mutation associated with MERRF syndrome (Brini et al., 1999). Finally, since the 
oxidative damage to proteins was accumulated in the defective mitochondria from the affected 
tissue cells, an efficient mitochondrial protein quality control system was also essential for the 
survival of patients with mitochondrial encephalomyopathies (Luce et al., 2010). It has been 
reported that the mitochondrial Lon protease and heat-shock protein 60 (HSP60) were 
dysregulated in cultured skin fibroblasts established from patients with MERRF and MELAS 
syndromes, respectively (Wu et al., 2010). In addition, the decreased expression of 
mitochondrial HSP60 within the abnormal mitochondria was found in the subsarcolemmal 
region of muscle from the patients with mitochondrial encephalomyopathies, but HSP60 was 
over-expressed in the intermyofibrillar mitochondria (Carrier et al., 2000). This finding 
suggests that the processing and integration of imported precursor proteins are impaired in 
the subsarcolemmal mitochondrial aggregates of the ragged-red fibers (RRF), whereas the 
biosynthesis, import and assembly of proteins may still be efficient in the biogenesis of 
intermyofibrillar mitochondria of these muscle fibers. 
4. Mitochondrial dysfunction-induced cell death and mitochondrial 
encephalomyopathies 
Evidence showed that tissue degeneration caused by cell death has been implicated in 
numerous mitochondrial diseases including mitochondrial encephalomyopathies, 
neuromuscular disorders and neurodegenerative diseases (Sayre et al., 2008). It is 
important to unravel the molecular mechanism underlying decreased cell viability in the 
process of epileptogenesis in the mitochondrial encephalomyopathies. There are at least 
two mechanisms implicated in neuronal cell death, including activation of the excitotoxic 
cascades (mitochondrial Ca2+ overload; excessive stimulation of glutamate receptors, 
nitric oxide overproduction; elevated oxidative stress and ROS overproduction), and 
induction of apoptosis. In this section, we focus on the involvement of programmed cell 
death (apoptosis) in the mitochondrial encephalomyopathies and provoked epilepsy. 
Apoptosis is the best understood cell death that can could be manipulated to control the 
destiny of cells. Indeed, apoptotic pathway has been considered a major physiological 
process in triggering cell death, which is critical for morphogenesis, tissue homeostasis as 
well as pathogenesis of diverse diseases (Hetts, 1998). Notably, mitochondria play an 
important role in the initiation, execution and regulation of apoptosis since mitochondria 
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can release specific proteins and factors to trigger the apoptotic pathway. MtDNA 
mutation-elicited mitochondrial dysfunction may result in insufficient supply of ATP, 
excess generation of ROS, elevated oxidative stress, membrane lipids peroxidation, 
disruption of mitochondrial membrane potential, dysregulation of excitotoxicity, and 
imbalanced distribution of intracellular Ca2+ ions (Kann & Kovacs, 2007). All of these 
changes can trigger activation of the cascades of caspases and pro-apoptotic proteins, and 
result in apoptosis.  
Clinically, many researchers tried to clarify the correlation between apoptosis-related cell 
death and pathogenic mechanism involved in the defects in muscle and brain of patients 
with mitochondrial encephalomyopathies. Many well-documented studies have revealed 
that apoptosis is involved in the progression of muscle myopathy (Aure et al., 2006; Umaki 
et al., 2002). Studies showed significant signs of apoptosis in the COX- negative muscle 
fibers in muscle biopsies from patients who harbored high proportions of specific point 
mutations in tRNA genes of mtDNA. Distinct expressions of 8-OHdG, 4-HNE, Mn-SOD, 
cytochrome c and DNase I were detected in the COX-negative muscle fibers accompanied 
by apoptotic markers. These results suggest the importance of apoptosis and the 
relationship of the oxidative stress with the severity of the muscle myopathy in 
mitochondrial diseases. Liu and coworkers also showed progressive cortical volume loss in 
patients with recurrent neocortical epilepsy (Liu et al., 2003). Accumulating evidence 
substantiated that apoptosis plays a role in seizure-induced neuron death as well as brain 
damages and also as a cause and consequence for epileptogenesis (Chuang et al., 2009b; 
Weise et al., 2005). It has been reported that an increase in the expression of caspases 
molecules was observed in temporal cortex of patients with epilepsy (Henshall et al., 2000). 
Increased production of ROS, NO and peroxynitrite was also reported to proceed apoptotic 
cell death in vulnerable brain regions (Chuang et al., 2009a, 2009b). On the other hand, 
inhibition of pro-apoptotic proteins and caspases activation could reduce seizure-induced 
neuronal cell death in experimental animal models. It has been reported that inhibition of 
caspase 3 was efficacious in the protection against neuronal cell loss in several models of 
brain injury (Liou et al., 2003). Either by short interfering RNA molecules targeting Bim in 
human cells or by knockout of Bim in a mouse model could reduce cell death and decrease 
the degeneration of hippocampal CA3 neurons following seizures (Murphy et al., 2010). In 
addition, the mice lacking the pro-apoptotic protein, Puma, were found to have a reduced 
neuronal death by 50% in the hippocampus (Engel et al., 2010). Moreover, a recent study 
also showed that Bcl-w was an endogenous neuroprotectant in mice and patients with 
temporal lobe epilepsy (Murphy et al., 2007).  
The above-mentioned studies showed the potential neuroprotective effect in epilepsy by 
targeting apoptosis with caspase inhibitors and genetic manipulation of pro-apoptotic 
proteins after onset of seizures in animals. Targeting apoptosis signaling pathways to 
prevent mitochondrial dysfunction-induced neuronal cell death may be a potential strategy 
for treatment of the patients with mitochondrial encephalomyopathies. However, some 
researchers showed that reducing cell death by administration of apoptotic inhibitor had no 
improvement of epilepsy symptoms in experimental animals (Narkilahti et al., 2003). These 
results revealed the complex cause and consequence of epileptogenesis and epileptic 
seizures. Therefore, the approach of inhibiting apoptosis to improve epileptic seizures 
should be evaluated with caution although it is still a potential candidate to collaborate with 
other antiepileptic drugs. 
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5. Mechanism of mitochondrial dysfunction caused neuronal excitability 
Abnormality of Ca2+ homeostasis is thought to be associated with the pathophysiology of 
neurodegenerative diseases (Mattson, 2007). The disease progression in patients often 
occurred following epileptic seizures, a cardinal and early symptom of mitochondrial 
diseases, especially in MERRF and MELAS syndromes (Okumura et al., 2008). Investigators 
also demonstrated that defects of mitochondrial respiratory chain could evoke seizures by 
using partial inhibition of ETC enzymes to cause deficiency of cytochrome c oxidase 
(Yamamoto & Tang, 1996). During the episode of epileptic seizures, extreme neuronal cell 
activity is associated with excessive cytosolic Ca2+ influx. It is noteworthy that dysregulation 
of Ca2+ handling in neurons might be a consequence of mtDNA mutation. The energy 
deficiency and ROS overproduction are the major stressors in human cells harboring 
disease-associated mtDNA mutations, which play an important role in the induction of the 
signaling cascades emitted from dysfunctional mitochondria to the nucleus. The 
abnormality of Ca2+ homeostasis induced by insufficiency of cellular ATP and oxidative 
damage is a potential link between mitochondrial dysfunction and epilepsy-induced 
hyperexcitability in neurons of patients with mitochondrial encephalomyopathies.     
5.1 Redox modulation of Ca
2+
 homeostasis 
Mitochondria play an important role in the regulation of Ca2+ homoeostasis by effective Ca2+ 
buffering (Tang & Zucker, 1997). Mitochondria can transiently accumulate substantial 
amounts of Ca2+ from the cytosol through the rapid uptake and relatively slow release of the 
Ca2+ ions. Therefore, it is possible that mitochondrial defect could have an impact on Ca2+ 
homoeostasis in cells. Abnormal Ca2+ homoeostasis has been reported in various cell types 
with defects in mitochondrial OXPHOS function (Willems et al., 2008). Many studies also 
proved that cells with mtDNA mutations could result in the dysregulation of mitochondrial 
Ca2+ buffering and reduction of the Ca2+ influx. The increase in the concentration of cytosolic 
Ca2+ was observed in the fibroblasts from patients with mitochondrial encephalomyopathies 
including MELAS and MERRF. The affected cells have elevated levels of Ca2+ ions and 
cannot normally induce Ca2+ influx in response to agonist-stimulated Ca2+ uptake by 
mitochondria (Brini et al., 1999; Moudy et al., 1995). It remains unclear as to how a 
pathogenic mtDNA mutation affects Ca2+ homeostasis. It is thought that mitochondrial Ca2+ 
uptake is dependent on the mitochondrial membrane potential, and thus mitochondrial 
deficiency-related decline of membrane potential plays an important role in defects of Ca2+ 
homeostasis. It has been proved that diminishment of mitochondrial membrane potential by 
an uncoupling agent can interfere with the uptake of Ca2+ by mitochondria and thus alter 
the transient cytosolic Ca2+ levels in neurons (Werth & Thayer, 1994). Indeed, defect in the 
mitochondrial Ca2+ handling was observed in the skin fibroblasts of patients with the 
MERRF syndrome. It was reported that cybrids harboring mtDNA mutation derived from a 
patient with MERRF syndrome exhibited a reduced uptake of the Ca2+ ions by mitochondria 
in response to histamine stimuli (Brini et al., 1999). 
Another important factor involving in the dysregulation of cellular Ca2+ homeostasis is 
excessive ROS production induced by mitochondrial dysfunction. More and more studies 
have supported that ROS and cellular redox state can directly modulate Ca2+ signaling 
through regulation of ion transporters (Hool & Corry, 2007). ROS have been shown to 
increase the Ca2+ channel activity through directly oxidizing the redox-sensing thiols on the 
Ryanodine receptor channel, and thereby induce the Ca2+ uptake from plasma membrane 
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(Werth & Thayer, 1994), and on IP3 receptor mediating Ca2+ release from ER which leads to 
elevated cytosolic Ca2+ (Suzuki & Ford, 1992). On the other hand, alteration of cellular redox 
states such as the lower GSH/GSSG and NADH/NAD+ ratios have been reported to 
modulate Ca2+ homeostasis by elevating the activity of Ca2+ channels and inhibiting the Ca2+ 
pump (Kourie, 1998; Zima et al., 2004). In general, Ca2+ can be re-uptake by the SR/ER Ca2+ 
ATPase following Ca2+ release from SR/ER Ca2+ stores or Ca2+ influx from PM to maintain 
the concentration of cytosolic Ca2+. However, the Ca2+ ATPase activity is also sensitive to the 
redox state, but unlike activation of oxidized receptor channels, it is inhibited by oxidative 
modification and ROS (Kaplan et al., 2003). As described above, mtDNA mutations can elicit 
over-production of intracellular ROS, which not only damages cellular biomolecules but 
also change the redox homeostasis of affected cells. Elevated oxidative stress results in a 
decrease of the GSH/GSSG ratio in the skin fibroblasts and cybrids harboring mtDNA 
mutation established from patients with mitochondrial diseases. A decrease in the GSH 
levels and gluthathione reductase activity has been observed in the plasma and brain 
regions of epileptic patients (Mueller et al., 2001). A large amount of studies have shown 
that the GSH concentration and the activity of Na+/K+ ATPase were decreased and affected 
the Ca2+ pump in the striatum and hippocampus during pilocarpine-induced seizures. It 
was also demonstrated that restoration of the level of GSH by lipoic acid could abolish the 
seizure episodes in the rat (de Freitas, 2010). A recent study showed that the tissue levels of 
GSH, and GSH/GSSG ratio were persistently altered throughout the onset of 
epileptogenesis in experimental temporal lobe epilepsy (Waldbaum et al., 2010b). The shift 
of redox state to oxidation would disrupt the Ca2+ homeostasis through the stimulation of 
Ca2+ influx and the interference of the Ca2+ pump, leading to dysregulation of the cytosolic 
Ca2+ concentration and the perturbation of Ca2+ signaling pathways. These findings imply 
that redox-dependent alterations of Ca2+ signaling cascades may contribute to the onset and 
progression of epileptogenesis.  
5.2 Inhibition of Ca
2+
 exchangers by energy deficiency  
The defects in the respiration and OXPHOS cause a depletion of ATP, and thus compromise 
the removal of Ca2+ ions by Ca2+-ATPase. Cytoplasmic Ca2+ concentration is also maintained 
by the ATP-dependent Ca2+ pump (Leo et al., 2005). Therefore, reduction in ATP synthesis 
could result in the accumulation of cytosolic Ca2+ (Buttgereit & Brand, 1995). A reduction in 
the capacity of Ca2+ clearance might lead to a disruption of Ca2+ homeostasis. Besides, lactic 
acidosis might be associated with an increase of cytosolic Ca2+ ions in patients with 
mitochondrial diseases. An increase in glucose uptake and the rate of glycolysis was 
observed in the epileptic loci during seizure episodes, which may result in elevated lactate 
production that is well documented in patients with mitochondrial diseases (Cornord et al., 
2002). Intracellular acidification has been shown to inhibit the plasma membrane Na+/H+ 
exchanger (Anderson et al., 2003), which causes an increase in cytosolic Na+ concentration 
and thus interfere with Na+/Ca2+ exchange through inhibition of the exchange of cellular 
Ca2+ for extracellular Na+, leading to cellular accumulation of Ca2+ ions. These findings 
suggest that mitochondrial dysfunction-induced insufficient supply of ATP might be 
another important factor contributing to elevated seizure susceptibility in human epileptic 
patients through alteration of ion transporters. The scenario described above can explain 
why an elevation of cytosolic Ca2+ ions is often observed in human cells harboring 
pathogenic mtDNA mutations, especially from MERRF and MELAS patients, respectively.   
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5.3 Pathological effect of defective Ca
2+
 dyshomeostasis 
Proper regulation of the Ca2+ influx is critical to neuronal cell function, and to transduce 
electrochemical signals into molecular signals. Perturbed Ca2+ homeostasis would cause 
excessive amounts of Ca2+ within the neurons leading to dysfunction of a variety of cellular 
processes, followed by degeneration and cell death. When defective mitochondria alter the 
cellular Ca2+ dynamics, it might affect the specificity of Ca2+ signals and subsequently result 
in the induction of improper signaling cascades. Intriguingly, it has been reported that 
peripheral mitochondria accumulate more Ca2+ than do those in perinuclear region (Collins 
et al., 2002). We have observed that pathogenic mtDNA mutations can alter the distribution 
and movement of mitochondria, which would affect the regulation of local Ca2+ ions (Ma et 
al., 2005). Thus, the pathogenic deficit of Ca2+ signaling might further affect the brain 
function. Besides, slow elevation of cytosolic Ca2+ ions can lead to a corresponding increase 
in mitochondrial Ca2+ concentration. This physiological increase in mitochondrial Ca2+ ions 
could positively regulate mitochondrial metabolism through activation of TCA cycle 
enzymes, boosting the biosynthesis of reduced respiratory substrates, and stimulation of 
adenine nucleotide transporter (ANT) and Complex V to promote the production of ATP 
(Das & Harris, 1990; Mc Cormack & Denton, 1993). However, it has been proposed that the 
sustained uptake of mitochondrial Ca2+ results in the inhibition of Complex I and Complex 
III activities, which consequently increase the ROS production (Batandier et al., 2004; 
Jekabsone et al., 2003). When Ca2+ ions are overloaded to mitochondria, it temporarily 
provokes a pathological signal leading to the opening of the permeability transition pore 
(PTP) to block the intracellular Ca2+ homeostasis by Ca2+ release, and the subsequent 
induction of apoptosis through cytochrome c release (Crompton, 1999). Therefore, the 
great amplitude of Ca2+ transient in cells harboring a pathogenic mutation of mtDNA may 
increase the risk of inducing cell death processes. Aforementioned investigations have 
provided compelling evidence to support the notion that disturbed Ca2+ homeostasis 
elicited by mitochondrial dysfunction in the affected tissues, especially in the neurons of 
the patients, plays an important role in the epileptogenesis and disease progression of 
encephalomyopathies.  
6. Sirtuin-mediated cellular adaptation in epileptogenesis 
There are increasing evidence to reveal that sirtuins play a critical role in regulation of 
metabolism and the aging process through several pathways (Bordone & Guarente, 2005). 
Sirt1 is the most extensively studied sirtuin that mediates NAD+-dependent deacetylation of 
target proteins and thereby regulates many cellular functions. Overexpression or increase of 
the activity of Sirt1 has been reported to be neuroprotective in several neurodegenerative 
diseases. The most important mechanism contributory to Sirt1-induced protective effect is 
related to the regulation of cell survival (de Oliveira et al., 2010). In addition to alleviating 
the cell death and inducing the repair system, Sirt1 can modulate cellular response to 
oxidative stress and promote mitochondrial function (Gerhart-Hines et al., 2007). In human 
cells with mitochondrial dysfunction, increase of oxidative stress and damage may trigger 
apoptosis, which is closely related to seizure-induced cell loss. To cope with oxidative stress, 
the antioxidant defense system has evolved to dispose of excess intracellular ROS. Indeed, 
an imbalanced expression of antioxidant enzymes has been reported in different brain 
regions of animals in several studies of experimental status epilepticus. Induction of Mn-
SOD and catalase expression was observed in picrotoxin-induced seizures. The catalase 
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levels have been also reported to increase following electrically induced seizures (de Freitas, 
2009). Contrary to Mn-SOD and catalase, the GPx showed a tendency to decrease in the 
animals with status epileptic seizures (Shin et al., 2008). Interestingly, the abnormal 
expression of antioxidant enzymes was commonly found in the affected tissues of patients 
with mitochondrial encephalomyopathies caused by pathogenic mtDNA mutations. In 
previous studies, we observed increased levels of intracellular ROS and imbalanced 
expression of antioxidant enzymes in skin fibroblasts established from patients with the 
MERRF syndrome (Wu et al., 2010). Increase in the expression and activity of Mn-SOD 
rather than other antioxidant enzymes was observed in skin fibroblasts from MERRF and 
CPEO patients, respectively, which suggests that the expression of antioxidant enzymes was 
altered and failed to cope with the increase of oxidative stress in tissue cells with 
mitochondrial defects. Recent studies showed that Sirt1 plays a critical role in the 
detoxification of ROS since it can deacetylate and activate some of the Foxo family proteins, 
which in turn increase the transcription of Mn-SOD and catalase genes expressions(Brunet 
et al., 2004). Several studies have suggested that Sirt1 is a stress responsive gene. In one of 
our previous studies, we showed that oxidative stress could increase Sirt1 protein 
expression in human skin fibroblasts upon treatment with 150-300 μM H2O2 (Wu et al., 
2010). Increased Sirt1 protein expression was also observed in skin fibroblasts from patients 
with some of the mitochondrial diseases as compared to normal subjects. Therefore, it is 
possible that increased expression of Sirt1 in affected tissue cells of patients with 
mitochondrial encephalomyopathies could lead to abnormal expression of antioxidant 
enzymes in response to mitochondrial dysfunction, which might contribute to epileptic 
conditions.  
On the other hand, Sirt1 may exert the calorie restriction-induced anti-aging effect by 
modulation of the mitochondrial function. It can promote mitochondrial respiration through 
deacetylation and activation of the transcription activity of PGC-1ǂ, a master regulator of 
mitochondrial biogenesis (Nemoto et al., 2005). It is well known that mitochondrial 
biogenesis is induced in the affected tissue cells of patients with mitochondrial diseases as a 
compensatory adaptation to compromised bioenergetic function due to defects in OXPHOS, 
despite the fact that increase in the number of mitochondria might have little contribution to 
the bioenergetic outcome. In one of our previous studies, we demonstrated that most of the 
patients with mitochondrial diseases frequently display abnormal mitochondrial 
proliferation along with an increase in the mitochondrial mass and gene expression of 
mtTFA (Wu et al., 2010). In addition, we also showed that increased oxidative stress is 
involved in the aberrant mitochondrial proliferation. Similarly, a change in the number of 
mitochondria has been reported in some of the patients with seizures or epilepsy. These 
findings led us to conjecture that compensatory induction of Sirt1 elicited by oxidative stress 
may be responsible for the unusual cellular status and neurotoxicity in epileptics. This also 
suggests that Sirt1 may be involved in the signaling pathway of the cross-talk between 
defective mitochondria and the nucleus to regulate cellular adaptation to mtDNA mutation-
elicited oxidative stress. 
7. Therapeutic approaches to target mitochondrial bioenergetics and 
oxidative stress in epilepsy  
Therapies for epileptic seizures have largely focused on reducing neuronal excitability and 
hence alleviating the frequency of occurrence of seizures and epilepsy. Recent therapeutic 
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approaches tend to seek for antiepileptogenic drugs that may inhibit the targets involved in 
the pathogenesis of epileptogenesis. Mitochondrial dysfunction triggering neuron cell death 
has been considered as a major contribution to the onset of seizures and is related to the 
resistance to epileptic therapy. Thus, therapies targeting mitochondrial bioenergetics and 
oxidative stress pathways could have neuroprotective effect and would be able to improve 
the seizure activity and attenuate the severity of epilepsy. Administration of creatine is 
frequently used and has been shown to protect brain injury in animal models of ALS, 
Huntington’s disease and MPTP-induced Parkinsonism (Ferrante et al., 2000; Matthews et 
al., 1999). Creatine can move through blood to brain and increase the pool of 
phosphocreatine/creatine by mitochondrial creatine kinase to boost the neuronal energy 
level. Supplementation of creatine was observed to attenuate hypoxia-induced seizures in 
both rats and rabbits. Creatine was also found to be neuroprotective in epilepsy induced by 
pilocarpine (Holtzman et al., 1998). These observations suggest that creatine treatment has 
the potential neuroprotective effect for patients with epilepsy, although it remains to be 
proven by clinical trials. Additionally, diet modification by caloric restriction or ketogenic 
diet has been used to inhibit seizure susceptibility in epileptic EL mice through a reduction 
of glucose metabolism (Todorova et al., 2000). Accumulating evidence support that chronic 
use of ketogenic diet can alter mitochondrial function, which includes promotion of 
mitochondrial biogenesis, decrease of ROS production and induction of GSH biosynthesis 
that ultimately lead to cellular adaption and restoration of mitochondrial redox state (Jrrett 
et al., 2008).  
On the other hand, to interfere with increased ROS during the onset of epilepsy appears to 
be another possible strategy for therapy. Natural antioxidant compounds such as vitamin C 
and E, melatonin and catalase have been shown to decrease oxidative stress and alleviate 
the seizure-induced brain injury (MacGrego et al., 1996; Tan et al., 1998). It has been 
reported that clinical trial of vitamin E as a therapy for epilepsy is controversial because it 
failed to improve seizure activity in pediatric patients. Similarly, although the Mn-SOD 
knockout mice was shown to exhibit age-dependent spontaneous and handling-induced 
seizures (Liang & Patel, 2004), and even more susceptible to kainate-induced seizures and 
neuron cell death, the SOD mimetics only reduced oxidative stress and oxidative damage 
but not the behavioral seizures (Rong et al., 1999). Hence, the therapeutic effect of 
antioxidants on epileptogenesis remains to be further investigated.           
8. Conclusion  
Mitochondrial dysfunction has been identified as a potential cause of epileptic seizures. 
Specific mtDNA mutations leading to the impairment of mitochondrial respiration and 
OXPHOS might be associated with epileptic phenotype. Because mitochondria supply the 
majority of ATP in neurons by OXPHOS and maintain the cellular Ca2+ homeostasis, their 
dysfunction can influence neuronal excitability and synaptic transmission, which may be 
responsible for epileptogenesis. Mitochondria play critical roles in energy metabolism, 
apoptosis and Ca2+ homeostasis, and respond to intrinsic and external stimuli through a 
variety of retrograde signaling pathways. Thus, mitochondrial dysfunction may trigger 
events involved in the cascades of the communication between mitochondria and the 
nucleus to mediate physiological adaptation of human cells through genetic or metabolic 
regulation. This may subsequently lead to alterations of the antioxidant defense system, 
activation of Ca2+ signaling, modulation of mitochondrial biogenesis and OXPHOS function. 
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The energy deficiency and ROS overproduction are the major stressors in human cells 
harboring disease-associated mtDNA mutations, which may play an important role in the 
induction of the retrograde signaling cascades sent from dysfunctional mitochondria to the 
nucleus. These events could interfere with Ca2+ homeostasis through decrease of the 
mitochondrial Ca2+ buffering capacity and affecting the Ca2+ influx and pump, which lead to 
the abnormal change of the cytosolic Ca2+ concentration and perturbation of Ca2+-related 
signaling pathways that ultimately trigger the neuronal cell death. Therefore, it is reasonable 
to consider mitochondria as promising targets of neuroprotective treatment of the patients 
with epilepsy. In conclusion, a better understanding of the mechanisms underlying 
epileptics elicited by mitochondrial dysfunction will provide novel information for the 
design of therapeutic approaches to treat patients with epilepsies or seizures caused by or 
associated with mitochondrial encephalomyopathies. 
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